Erythrocytes identify complement activation in patients with COVID-19

被引:30
作者
Lam, L. K. Metthew [1 ,2 ]
Reilly, John P. [1 ,2 ]
Rux, Ann H. [3 ]
Murphy, Sophia J. [1 ]
Kuri-Cervantes, Leticia [4 ,5 ]
Weisman, Ariel R. [1 ]
Ittner, Caroline A. G. [1 ]
Pampena, M. Betina [4 ,5 ]
Betts, Michael R. [4 ,5 ]
Wherry, E. John [5 ,6 ,7 ]
Song, Wen-Chao [5 ,6 ]
Lambris, John D. [3 ]
Meyer, Nuala J. [1 ,2 ,5 ,8 ]
Cines, Douglas B. [2 ,3 ,5 ]
Mangalmurti, Nilam S. [1 ,2 ,5 ,8 ]
机构
[1] Univ Penn, Div Pulm Allergy & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA
[5] Univ Penn, Penn Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA
[6] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA
[7] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA
[8] Univ Penn, Perelman Sch Med, Lung Biol Inst, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
complement; COVID-19; erythrocyte; SARS-CoV-2; sepsis;
D O I
10.1152/ajplung.00231.2021
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
COVID-19, the disease caused by the SARS-CoV-2 virus, can progress to multisystem organ failure and viral sepsis characterized by respiratory failure, arrhythmias, thromboembolic complications, and shock with high mortality. Autopsy and preclinical evidence implicate aberrant complement activation in endothelial injury and organ failure. Erythrocytes express complement receptors and are capable of binding immune complexes; therefore, we investigated complement activation in patients with COVID-19 using erythrocytes as a tool to diagnose complement activation. We discovered enhanced C3b and C4d deposition on erythrocytes in COVID-19 sepsis patients and non-COVID sepsis patients compared with healthy controls, supporting the role of complement in sepsis-associated organ injury. Our data suggest that erythrocytes may contribute to a precision medicine approach to sepsis and have diagnostic value in monitoring complement dysregulation in COVID-19-sepsis and non-COVID sepsis and identifying patients who may benefit from complement targeted therapies.
引用
收藏
页码:L485 / L489
页数:5
相关论文
共 50 条
[21]   Complement activation in COVID-19 and targeted therapeutic options: A scoping review [J].
Lim, Endry Hartono Taslim ;
van Amstel, Rombout Benjamin Ezra ;
de Boer, Vieve Victoria ;
van Vught, Lonneke Alette ;
de Bruin, Sanne ;
Brouwer, Matthijs Christian ;
Vlaar, Alexander Petrus Johannes ;
van de Beek, Diederik .
BLOOD REVIEWS, 2023, 57
[22]   Enhanced complement activation and MAC formation accelerates severe COVID-19 [J].
Ellsworth, Calder R. ;
Chen, Zheng ;
Xiao, Mark T. ;
Qian, Chaosi ;
Wang, Chenxiao ;
Khatun, Mst Shamima ;
Liu, Shumei ;
Islamuddin, Mohammad ;
Maness, Nicholas J. ;
Halperin, Jose A. ;
Blair, Robert V. ;
Kolls, Jay K. ;
Tomlinson, Stephen ;
Qin, Xuebin .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 81 (01)
[23]   IP-10 and complement activation as friend or foe in COVID-19 [J].
Bunprakob, Saowalak ;
Hemachudha, Pasin ;
Ruchisrisarod, Chanida ;
Supharatpariyakorn, Thirawat ;
Hemachudha, Thiravat .
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2022, 36
[24]   Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease [J].
Medjeral-Thomas, Nicholas R. ;
Troldborg, Anne ;
Hansen, Annette G. ;
Gisby, Jack ;
Clarke, Candice L. ;
Prendecki, Maria ;
McAdoo, Stephen P. ;
Sandhu, Eleanor ;
Lightstone, Liz ;
Thomas, David C. ;
Willicombe, Michelle ;
Botto, Marina ;
Peters, James E. ;
Pickering, Matthew C. ;
Thiel, Steffen .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[25]   The Interaction of Complement and Intrinsic Coagulation System: A Comparative Study between COVID-19 and Bacterial Sepsis Patients [J].
Papadakis, Dimitrios-Dorotheos ;
Politou, Marianna ;
Pittaras, Theodoros ;
Stergiou, Ioanna E. ;
Koutsoukou, Antonia ;
Kompoti, Maria ;
Vasileiadis, Ioannis .
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (18)
[26]   Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection [J].
Avraham, Maya ;
Sinkovits, Gyorgy ;
Hurler, Lisa ;
Prohaszka, Zoltan ;
Fishelson, Zvi .
FRONTIERS IN IMMUNOLOGY, 2024, 15
[27]   Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 Mortality [J].
Defendi, Federica ;
Leroy, Corentin ;
Epaulard, Olivier ;
Clavarino, Giovanna ;
Vilotitch, Antoine ;
Le Marechal, Marion ;
Jacob, Marie-Christine ;
Raskovalova, Tatiana ;
Pernollet, Martine ;
Le Gouellec, Audrey ;
Bosson, Jean-Luc ;
Poignard, Pascal ;
Roustit, Matthieu ;
Thielens, Nicole ;
Dumestre-Perard, Chantal ;
Cesbron, Jean-Yves .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[28]   An update: the emerging evidence of complement involvement in COVID-19 [J].
Qin Li ;
Zi Chen .
Medical Microbiology and Immunology, 2021, 210 :101-109
[29]   Complement and protection from tissue injury in COVID-19 [J].
Ortiz, Alberto .
CLINICAL KIDNEY JOURNAL, 2020, 13 (05) :734-738
[30]   The interplay between neutrophils, complement, and microthrombi in COVID-19 [J].
Zuo, Yu ;
Kanthi, Yogendra ;
Knight, Jason S. ;
Kim, Alfred H. J. .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2021, 35 (01)